Global Sanger sequencing market expected to exceed $10,130.6 million by 2031, driven by genomics advancements.

From GlobeNewswire: 2024-06-19 05:40:00

The global Sanger sequencing market is set to reach USD 10,130.6 million by 2031, with a CAGR of 18.2%. Cancer genomics and pharmacogenomics are driving growth by identifying genetic mutations for personalized treatments. Advancing technologies and rising chronic diseases are boosting demand. Integration of AI and machine learning is a key trend, while targeted gene sequencing and personalized medicine are poised for significant growth. Key players in the market include Thermo Fisher Scientific and QIAGEN.
In May 2023, Source Genomics opened a new lab in North England for faster Sanger sequencing services. The Tamil Nadu Forest Department launched a DNA sequencing facility in India. The global Sanger sequencing market is projected to grow at a CAGR of 18.2% from 2024 to 2031. North America is expected to dominate the market, with key players focusing on new product launches and mergers to enhance their market position. Forecasts show a promising future for the market due to increased application in disease diagnostics and genetic research.



Read more at GlobeNewswire: Global Sanger Sequencing Market Size To Exceed USD 10,130.6